Cryptococcosis Treatment Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2027, at CAGR of 4.4 % during forecast period of 2019 to 2027.
To know about the Research Methodology :- Request Free Sample Report Cryptococcosis is a fungal disease. It is an infection caused by inhaling the fungus caused either by Cryptococcus neoformans or Cryptococcus gattii. The disease is spread through breathing of fungus related to bird species. The fungus mostly affects the lungs, but it has the potential to spread to the brain, called meningitis. The symptoms of the disease such as dry cough, fever, headache, blurred vision and fatigue. Cryptococcosis can be treated by giving dozes of amphotericin B, flucytosine and fluconazole. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Cryptococcosis Restrains
Treatment
Market
Drivers
and
Rise in occurrence of fatal fungal disease, last-stage HIV patients developing the disease and availability of advanced treatment options are driving the growth of Cryptococcosis market globally. The increasing number of HIV patients are providing an up thrust to the market. According to recent study, it has been found that the death of XX % of HIV patients is because of improper treatment of cryptococcosis. HIV patients are immunocompromised and have a weak immune system, thus making an easy entry into the body for such fungus. In developing countries, people are not diagnosed early due to a lack of diagnostic tests, therefore affecting the Cryptococcosis Treatment market. According to Centers for Disease Control and Prevention states that around X million cryptococcosis cases rise throughout